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Autoinoculation as a treatment modality for molluscum contagiosum: A preliminary uncontrolled trial
Sir, Molluscum contagiosum (MC) is a self-limiting skin infection caused by poxvirus, commonly seen in children with a prevalence of 8-12%. Infection follows contact with infected persons or contaminated objects, and the diagnosis is clinical. Homologous autoimplantation is a simple technique which helps in inducing a cell-mediated immune responseto the antigens, aiding clearance of both local and distant lesions. Previous experience of good clearance of verruca vulgaris by autoimplantation prompted us to assess the utility of this technique in molluscum contagiosum.
A prospective study was conducted in the Department of Dermatology of MDM hospital, Dr SN medical college, Jodhpur for 6 months among 58 patients. The patients were subjected to complete work up including detailed history and examination of lesions. Except lactating mothers, pregnant/immunosuppressed patients, and those with a history of intake of immunomodulatory/immunosuppressive drugs we included all clinically diagnosed cases in our study. Institutional ethical clearance and proper written consent was obtained after counseling, and a treatment free washout period of 3 months was ensured. A single session of autoinoculation was performed. The patients were followed up at 7 days, and thereafter every 2 weeks for 3 months to look for clearance and another 3 months to check for relapse.
The response to therapy was graded as follows: • Excellent, >75% of lesions disappeared • Good, 51-75% lesions disappeared • Average, 26-50% lesions disappeared • Poor <25% lesions disappeared.
A well-developed lesion was chosen as a donor, under topical anesthesia, and using all aseptic precautions, it was approached using an insulin syringe and pierced from a site just adjacent to the lesion. It was then repeatedly punctured from within 5-7 times to expose the contents of the molluscum body to the dermis by crossing basement membrane, hence inoculating and exposing the viral antigen to the immunological surveillance system. After the procedure fusidic ointment was applied locally over the punctured site [ Figure 1 ].
A total of 32 (55.2%) patients showed complete resolution of the lesions within 3 months. There was partial response Week 1
Week 3
Week 5
Weeks Number and percentage of patients
Week 7
Week 9 Week12 % of pt showing clearance of lesion no of patients lesions or checking for serospecific antibodies. Spontaneous clearance of molluscum lesions during the trial could not be excluded, and thus a placebo controlled trial would be necessary to establish the exact therapeutic efficacy.
The modified technique of autoimplantation of molluscum is a safe, effective, and rapid procedure for its treatment. Our study indicates that autoinoculation therapy holds promise in the management of this infection. Being an easy day-care procedure, it is also a cost-effective option.
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Nil. Figure 3 ]. We also noted the total number of lesions, mean, standard deviation, and range of number of lesion at each follow-up visit. A steady decrease in both the total and mean number of lesions was observed [ Table 1 and Figure 4 ]. Local adverse events were mild erythema, edema, and postinflammatory hyperpigmentation.
The molluscum virus infection is localized to the epidermal layers where it induces a typical, complex hyperproliferative lesion with an abundance of virus particles but a conspicuous, absence of immune response. By not crossing the basement membrane the virus evades immune surveillance. The lesions are often self-limiting as most of them resolve without treatment, with the average length of infection lasting between 6 and 18 months. 1 Physical destruction has been recommended as the preferred method for treatment by many authors. 2 Lesion eradication may also be attempted chemically (trichloroacetic acid, tretinoin) or immunologically (imiquimod), inciting an inflammatory response which upregulates the immune system to clear the infection. 3 Topical cidofovir has been used in the immunosuppressed population but has not been systemically studied in the general population. 4, 5 Hence, for effective control, there should be immune stimulation which can lead to long-term immunity against the virus. Molluscum virus is an orthopox virus which is closely related to varicella and vaccinia viruses, and a similar approach has been successful in generating immune response againsta vaccinia and varicella viruses by vaccination.
Various studies on autoimplantation in warts were shown to be associated with the production of Th1 cytokines (TNF-α, and IL-1) which downregulate the transcription of genes whereas INF-γ and IL-2 stimulate cytotoxic T cells and natural killer cells to eradicate the infected cells. 6 Limitations of our study were a small sample size, lack of controls to assess spontaneous resolution, and lack of serotyping of persistent
Handheld narrow band ultraviolet B comb as home phototherapy device for localised vitiligo: Dosimetry and calibration
Sir, Phototherapy is an established therapeutic modality for vitiligo with high repigmentation rates and good safety profile. Narrowband-UVB (NB-UVB) involves the use of UV-lamps with peak emission at 311 nm. The efficacy of NB-UVB in vitiligo was first demonstrated by Westerhof and Nieuwboer-Krobotova in 1997, and since then, several clinical studies have demonstrated its effectiveness in both generalized and localized vitiligo. 1,2 NB-UVB therapy is currently being administered in whole body chambers which are usually available in tertiary care hospitals. This is an expensive equipment, requires regular hospital visits, and is inconvenient for patients travelling long distance for therapy, in addition to resulting in loss of wages for the patients and their attendants. To overcome these significant disadvantages of whole body cabinets, home-based NB-UVB therapy is the need of the hour; such devices are being used in both vitiligo and psoriasis with encouraging results. 3, 4 In addition, unnecessary exposure to uninvolved body sites in whole body cabinets would be circumvented by targeted home phototherapy devices. A home-based phototherapy unit that has been found as effective in psoriasis as the outpatient NB-UVB chamber, in a comparative trial, consists of 2 Philips TL-9 W/01 lamps and delivers NB-UVB at irradiance of 10 mW/cm 2 , over a 9 × 7 cm area for the treatment of localized lesions. 4 Several other studies have also documented the safety of home phototherapy. 5 Numerous portable and lightweight handheld NB-UVB devices are now available in the market. NB-UVB comb is marketed in India primarily for the treatment of scalp psoriasis. It consists of two Philips TL-9W/01 NB-UVB lamps placed in a plastic casing that emit wavelength of 310-315 nm (peak 311 nm) over an 11 × 4 cm area, on which parallel arrays of toothed structures of approximately 2 cm length (comb) are attached [ Figure 1 ]. The comb is for removing thick scales present on the psoriatic plaques to adequately expose the lesions to NB-UVB radiation. We intend to use this equipment for delivering NB-UVB to localized patches of vitiligo on domiciliary basis. This equipment has been chosen because it is lightweight, handheld, easily available, easy to maintain and store, and inexpensive. The toothed structures or comb would maintain a uniform distance between the NB-UVB lamps and vitiligo patches. However, there is no data on irradiance measurements from these devices. Irradiance is defined as radiant power incident on a surface from all forward angles, per unit area, expressed as W/m 2 or mW/cm 2 nm in a specified wavelength range. Fluence or dose is the energy incident on the skin during a treatment session calculated as follows: UVR dose = irradiance × treatment time. To use this equipment effectively, irradiance measurements should be made to assess the output from this device so that appropriate treatment protocol for vitiligo in terms of initial exposure time and increments of exposure to NB-UVB can be formulated. The present study was undertaken to determine the irradiance of handheld NB-UVB comb as a preliminary step to adopt it as a home phototherapy device in limited vitiligo.
A total of 22 handheld NB-UVB combs (V-Care Meditech Pvt. Ltd., Bangalore, India) were tested for irradiance measurement using an integrated UV meter (Herbert Waldmann GmbH and Co. KG Villingen-Schwenningen, Germany). The sensor of the UV meter was kept at a distance of approximately 2 cm from the lamp (length of the teeth of the NB-UVB comb) [ Figure 2 ]. The comb was switched on for 45 seconds to warm up the device and the irradiance was measured at 45 seconds, 1 minute, 2 minutes, 3 minutes, 4 minutes, and 5 minutes. This measurement was undertaken for all the devices.
There was a progressive decay in the irradiance of NB-UVB combs with time. The mean irradiance from 22 combs at 45 seconds was 6.84 mW/cm 2 (range 5.64-7.87), 6.5 (range 5.56-7.82) at 1 minute, 6.4 (range 5.26-7.22) at 2 minutes, 5.9 (range 4.94-6.71) at 3 minutes, 5.5 (range 4.62-6.25) at 4 minutes and 5.1 mW/cm 2
